RxDoctor Payments DataLook up a doctor →

Andrew Dublin, MD

Interventional Cardiology · Walnut Creek, CANPI 1215085246

Payments from drug & device makers

$443,752in general payments, 2019–2025

Across 759 payments — averaging $584.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$264K
  • Procyrion, Inc.$64K
  • CSL Behring$58K
  • Johnson & Johnson$19K
  • AstraZeneca$17K
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$9K
  • plus $13K from 46 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific60$264,113
Procyrion, Inc.2$63,785
CSL Behring48$58,094
Johnson & Johnson101$18,581
AstraZeneca49$17,119
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)51$8,826
Cathworks, Inc.16$2,689
Abbott35$1,001
Amgen42$846
AOP Health US, LLC1$812
Biotronik Inc.35$757
Boehringer Ingelheim29$646
Novartis37$594
E.r. Squibb & Sons, L.L.C.28$539
Pfizer29$494
Medtronic(2 entities)9$415
Abiomed10$406
Shockwave Medical, Inc7$399
Heartflow, Inc.13$380
Esperion Therapeutics, Inc.14$319
Philips North America LLC11$300
Amarin Pharma, Inc.18$298
Sanofi-aventis U.S. LLC14$250
Atricure, Inc.5$222
Lexicon Pharmaceuticals, Inc.16$156
Novo Nordisk5$151
Merck8$145
Kiniksa Pharmaceuticals International, PLC5$137
Impulse Dynamics (USA) Inc.5$124
Regeneron Healthcare Solutions, Inc.6$97
Kiniksa Pharmaceuticals, Ltd.4$89
Lundbeck LLC5$83
Bayer4$80
Cordis US CORP.4$79
Actelion Pharmaceuticals US, Inc.4$77
Cvrx, Inc.2$68
Bardy Diagnostics, Inc.2$65
Elutia, Inc.2$59
Irhythm Technologies, Inc.3$59
Kestra Medical Technology Services, Inc.3$58
Akcea Therapeutics, Inc.3$55
Alnylam Pharmaceuticals Inc.3$48
GSK2$38
Inari Medical, Inc.1$38
Angiodynamics, Inc.1$36
Siemens Medical Solutions USA, Inc.1$24
Biogen1$24
Terumo Medical Corporation1$18
Scpharmaceuticals Inc.1$18
Asahi Intecc USA, Inc.1$14
Edwards Lifesciences1$13
Baxter Healthcare1$13

How this compares

$443,752 in reported general payments places this provider in the 90th percentile of 585 interventional cardiology providers in California.

See all interventional cardiology providers in California →

Medicare billing

Part B allowed, 2024
$598,296
Medicare patients
2,069
Services billed
7,030

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in Walnut Creek

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →